Walker, Martin & Hatch provides regulatory and legislative consulting services.
1200 North Nash Street, Suite 1165 Arlington VA 22209, Arlington, VA · JACK MARTIN
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2013 | GLAXOSMITHKLINE |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$20,000 | — | |
| 2013 | NATURAL PRODUCTS ASSOCIATION |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$30,000 | — | |
| 2013 | WON-DOOR CORPORATION |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | — | |
| 2013 | GLAXOSMITHKLINE |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$22,500 | — | |
| 2013 | NATURAL PRODUCTS ASSOCIATION |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$20,000 | — | |
| 2013 | WON-DOOR CORPORATION |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | — | |
| 2013 | GLAXOSMITHKLINE |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$22,500 | — | |
| 2013 | NATURAL PRODUCTS ASSOCIATION |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$20,000 | — | |
| 2013 | WON-DOOR CORPORATION |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | — | |
| 2013 | NATURAL PRODUCTS ASSOCIATION |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$20,000 | — |
| Client | Filings | Total Income |
|---|---|---|
| GLAXOSMITHKLINE | 48 | $1,027,500 |
| NATURAL PRODUCTS ASSOCIATION | 42 | $741,600 |
| WON-DOOR CORPORATION | 30 | $350,000 |
| PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA | 24 | $660,000 |
| VERIZON | 22 | $593,000 |
| PHOENIX CAPITAL MANAGEMENT LLC | 13 | $220,000 |
| OVOS NATURAL HEALTH US LIMITED | 12 | $96,500 |
| PARRY ROMANI DECONCINI & SYMMS (ON BEHALF OF COALITION TO PRESERVE DESHEA) | 11 | $136,000 |
| RIVERTON CITY UTAH | 5 | $147,000 |
| CERMAR INVESTMENTS, LLC | 5 | $21,000 |
| QWEST COMMUNICATIONS | 2 | $82,500 |
| MICRON TECHNOLOGY INC | 2 | $60,000 |
| KRONOS LONGEVITY RESEARCH INST | 1 | $20,000 |
| Name | Disclosed Prior Position |
|---|---|
| VICTOR CABRAL | |
| SCOTT HATCH | N/A |
| JACK MARTIN | N/A |
| LAIRD WALKER | N/A |